54798-91-3 Usage
Uses
Used in Pharmaceutical Industry:
2,3-Dichloro-α-methylbenzenemethanol is used as a preservative for its antimicrobial properties to prevent the growth of bacteria, fungi, and other microorganisms in pharmaceutical products. This helps maintain the sterility and stability of medications, ensuring their safety and effectiveness for consumers.
Used in Personal Care Industry:
In personal care products, 2,3-Dichloro-α-methylbenzenemethanol is used as an antimicrobial agent and antiseptic. It helps prevent the growth of harmful microorganisms that can cause infections or spoilage, ensuring the safety and longevity of cosmetic and personal care items.
However, it is important to note that due to its potential toxicity, 2,3-Dichloro-α-methylbenzenemethanol should be handled and used with caution. Prolonged or excessive exposure to this chemical can cause respiratory irritation and other health concerns. Therefore, it is essential to follow proper safety guidelines and use it in accordance with recommended concentrations to minimize any risks.
Check Digit Verification of cas no
The CAS Registry Mumber 54798-91-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,7,9 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 54798-91:
(7*5)+(6*4)+(5*7)+(4*9)+(3*8)+(2*9)+(1*1)=173
173 % 10 = 3
So 54798-91-3 is a valid CAS Registry Number.
54798-91-3Relevant academic research and scientific papers
PYRIDINE DERIVATIVES AND APPLICATION OF ANTI-MACOBACTERIUM THEREOF
-
Paragraph 0490; 0492; 0493, (2016/10/08)
The present invention provides a series of pyridine derivatives and their preparation method and application thereof. The series of pyridine derivatives can be applied to treating mycobacterium-related diseases, especially to treatments of fatal mycobacterium-related diseases. The fatal diseases may be related to mycobacterium tuberculosis, mycobacterium bovis, mycobacterium avium, and mycobacterium marinum.
Process for the preparation of lamotrigine
-
, (2008/06/13)
The invention provides a process for producing lamotrigine of formula (I): STR1 which process comprises subjecting a compound of formula (II): STR2 wherein R is CN or CONH2, in an organic solvent, to ultra violet or visible radiation and, when R is CN, to heat.
Process for the preparation of lamotrigine
-
, (2008/06/13)
Lamotrigine, 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine, may be prepared by treating 6-(2,3-dichlorophenyl)-5-chloro-3-thiomethyl-1,2,4-triazine of formula (II) STR1 with ammonia. Precursors to the compound of formula (II), and their preparation, are also described.
